MCID: BZR001
MIFTS: 30

Bizarre Leiomyoma

Categories: Cancer diseases

Aliases & Classifications for Bizarre Leiomyoma

MalaCards integrated aliases for Bizarre Leiomyoma:

Name: Bizarre Leiomyoma 12 15 71
Pleomorphic Leiomyoma 12
Symplastic Leiomyoma 12
Atypical Leiomyoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:5127
NCIt 49 C4257
SNOMED-CT 67 48897006
UMLS 71 C0334478

Summaries for Bizarre Leiomyoma

Disease Ontology : 12 A leiomyoma that is characterized by large, atypical nuclei in otherwise normal appearing leiomyoma and rare or absent mitotic figures.

MalaCards based summary : Bizarre Leiomyoma, also known as pleomorphic leiomyoma, is related to cutaneous fibrous histiocytoma and leiomyoma cutis. An important gene associated with Bizarre Leiomyoma is PGR (Progesterone Receptor), and among its related pathways/superpathways are Chks in Checkpoint Regulation and Ovarian tumor domain proteases. Affiliated tissues include breast, uterus and smooth muscle, and related phenotype is Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435).

Related Diseases for Bizarre Leiomyoma

Diseases related to Bizarre Leiomyoma via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 221, show less)
# Related Disease Score Top Affiliating Genes
1 cutaneous fibrous histiocytoma 30.5 CLEC2A ACTC1
2 leiomyoma cutis 30.5 MED12 FH CLEC2A
3 gastric leiomyoma 30.2 FH CALD1
4 cellular leiomyoma 29.9 PCNA MED12 CALD1
5 intravenous leiomyomatosis 29.8 PGR ESR1 CALD1
6 leiomyoma 29.8 PGR PCNA MED12 FH ESR1 ACTC1
7 mesenchymal cell neoplasm 29.8 TP53 CALD1
8 carcinosarcoma 29.6 TP53 PGR ACTC1
9 endometrial adenocarcinoma 29.3 TP53 PGR ESR1
10 leiomyomatosis 29.3 PGR MED12 FH ESR1
11 leiomyoma, uterine 29.1 PGR MED12 FH ESR1
12 myoma 28.6 PGR MED12 FH ESR1 CALD1
13 smooth muscle tumor 28.6 PGR MED12 FH ESR1 CALD1 ACTC1
14 leiomyosarcoma 28.0 TP53 PSMB9 PGR MED12 FH ESR1
15 uterine corpus bizarre leiomyoma 12.5
16 calcifying aponeurotic fibroma 10.4 PGR ACTC1
17 glycogen-rich clear cell breast carcinoma 10.4 PGR ACTC1
18 benign metastasizing leiomyoma 10.4 PGR ACTC1
19 lymphangiomatosis 10.4 PGR PCNA
20 lymphangioma 10.4 PCNA ACTC1
21 breast myoepithelial carcinoma 10.4 PGR ACTC1
22 myxoid leiomyosarcoma 10.4 PGR ACTC1
23 eccrine papillary adenocarcinoma 10.3 PGR CLEC2A
24 benign breast phyllodes tumor 10.3 PGR MED12
25 pulmonary vein leiomyosarcoma 10.3 PGR CALD1
26 vagina leiomyoma 10.3 PGR CALD1
27 cystic nephroma 10.3 PGR ACTC1
28 infertility 10.3
29 apocrine sweat gland neoplasm 10.3 PGR CLEC2A
30 glomangiomyoma 10.3 CALD1 ACTC1
31 vaginal benign neoplasm 10.3 PGR CALD1
32 cervical polyp 10.3 PGR CALD1
33 glassy cell carcinoma of the cervix 10.3 PGR ESR1
34 bartholin's gland adenoid cystic carcinoma 10.3 PGR ESR1
35 chronic tympanitis 10.3 PGR ESR1
36 granulomatous endometritis 10.3 PGR ESR1
37 endometritis 10.3 PGR ESR1
38 breast juvenile papillomatosis 10.3 PGR ESR1
39 glomangioma 10.3 CALD1 ACTC1
40 mucinous cystadenocarcinoma 10.3 PCNA ACTC1
41 vulvar syringoma 10.3 PGR ESR1
42 trigonitis 10.3 PGR ESR1
43 breast scirrhous carcinoma 10.3 PGR ESR1
44 oncocytic breast carcinoma 10.3 PGR ESR1
45 uterus leiomyosarcoma 10.3 PGR CALD1
46 adult type testicular granulosa cell tumor 10.3 PGR ESR1
47 breast papillary carcinoma 10.3 PGR ESR1
48 liver leiomyoma 10.2 PGR ESR1
49 breast metaplastic carcinoma 10.2 PGR ESR1
50 mammographic density 10.2 PGR ESR1
51 epithelioid leiomyosarcoma 10.2 CALD1 ACTC1
52 lipid-rich carcinoma 10.2 PGR ESR1
53 atypical polypoid adenomyoma 10.2 MED12 CALD1
54 angiomyoma 10.2 CLEC2A CALD1
55 progesterone-receptor negative breast cancer 10.2 PGR ESR1
56 progesterone resistance 10.2 PGR ESR1
57 apocrine adenocarcinoma 10.2 PGR ESR1
58 gender identity disorder 10.2 PGR ESR1
59 breast osteosarcoma 10.2 PGR ESR1
60 cribriform carcinoma 10.2 PGR ESR1
61 meningioma, radiation-induced 10.2 PGR PCNA
62 breast neuroendocrine neoplasm 10.2 PGR ESR1
63 intracystic papillary adenoma 10.2 PGR ESR1
64 dartoic leiomyoma 10.2 FH CLEC2A
65 ovarian endometrial cancer 10.2 PGR ESR1
66 estrogen excess 10.2 PGR ESR1
67 progesterone-receptor positive breast cancer 10.2 PGR ESR1
68 syringoma 10.2 ESR1 CLEC2A
69 apocrine adenosis of breast 10.2 TP53 PGR
70 intraductal papilloma 10.2 PGR ESR1
71 pseudosarcomatous fibromatosis 10.2 CALD1 ACTC1
72 colon leiomyoma 10.2 MED12 FH
73 vaginal discharge 10.2 PGR ESR1
74 basal cell carcinoma 10.2
75 adenocarcinoma 10.2
76 pseudo-meigs syndrome 10.2
77 breast myofibroblastoma 10.2 ESR1 CALD1
78 necrotizing sialometaplasia 10.2 TP53 ACTC1
79 myoepithelial carcinoma 10.1 TP53 ACTC1
80 endometriosis of ovary 10.1 PGR ESR1
81 infantile myofibromatosis 10.1 CALD1 ACTC1
82 primary peritoneal carcinoma 10.1 TP53 PGR
83 dedifferentiated liposarcoma 10.1 TP53 ACTC1
84 gastric diffuse adenocarcinoma 10.1 TP53 PGR
85 inflammatory breast carcinoma 10.1 PGR ESR1
86 intravascular fasciitis 10.1 ESR1 CALD1
87 chickenpox 10.1 PGR ACTC1
88 granulosa cell tumor of the ovary 10.1 TP53 ACTC1
89 oral leukoplakia 10.1 TP53 PCNA
90 endometrial disease 10.1 PGR ESR1
91 chordoid glioma 10.1 TP53 PGR
92 vulvar disease 10.1 TP53 PGR
93 perivascular epithelioid cell tumor 10.1 PGR CALD1 ACTC1
94 hemangiopericytoma, malignant 10.1 CALD1 ACTC1
95 adenofibroma 10.1 TP53 ACTC1
96 benign meningioma 10.1 PGR PCNA
97 eccrine sweat gland cancer 10.1 TP53 CLEC2A
98 eccrine acrospiroma 10.1 TP53 CLEC2A
99 rhabdoid tumor predisposition syndrome 1 10.1 TP53 ACTC1
100 glomangiosarcoma 10.1 TP53 CALD1
101 birt-hogg-dube syndrome 10.1 FH CLEC2A
102 epithelial-myoepithelial carcinoma 10.1 TP53 ACTC1
103 testicular torsion 10.1 TP53 PCNA
104 papillary serous adenocarcinoma 10.0 TP53 PGR
105 clear cell basal cell carcinoma 10.0 TP53 CLEC2A
106 mature teratoma 10.0 TP53 PCNA
107 epidermal appendage tumor 10.0 TP53 CLEC2A
108 spindle cell carcinoma 10.0 PGR ESR1 ACTC1
109 angiomyolipoma 10.0 PGR ESR1 ACTC1
110 glomangiomatosis 10.0 TP53 CALD1
111 borst-jadassohn intraepidermal carcinoma 10.0 TP53 CLEC2A
112 pleomorphic carcinoma 10.0 TP53 PGR
113 prostatic hypertrophy 10.0 PGR PCNA ESR1
114 diffuse peritoneal leiomyomatosis 10.0 PGR MED12 FH
115 conventional fibrosarcoma 10.0 TP53 CALD1
116 gastric lymphoma 10.0 TP53 PCNA
117 uterine sarcoma 10.0
118 rare tumor 10.0
119 48,xyyy 10.0
120 polyploidy 10.0
121 wolffian duct adenocarcinoma 10.0 TP53 ESR1
122 pleomorphic rhabdomyosarcoma 10.0 TP53 ACTC1
123 endometrial clear cell adenocarcinoma 10.0 TP53 ESR1
124 sweat gland disease 10.0 PGR ESR1 CLEC2A
125 cutaneous leiomyosarcoma 10.0 FH CLEC2A ACTC1
126 angiolipoma 10.0 FH CLEC2A ACTC1
127 lung leiomyoma 10.0 PGR ESR1 CALD1
128 vagina leiomyosarcoma 10.0 PGR ESR1 CALD1
129 vaginal endometrial stromal sarcoma 10.0 PGR ESR1 CALD1
130 vagina sarcoma 9.9 PGR ESR1 CALD1
131 adult mesoblastic nephroma 9.9 PGR ESR1 CALD1
132 cystadenocarcinoma 9.9 TP53 PGR ACTC1
133 bladder cancer 9.9
134 bladder leiomyoma 9.9
135 inverted papilloma 9.9 TP53 PCNA
136 mucoepidermoid carcinoma 9.9 TP53 PCNA ACTC1
137 spiradenoma 9.9 TP53 CLEC2A ACTC1
138 liver leiomyosarcoma 9.9 PSMB9 CALD1
139 connective tissue benign neoplasm 9.9 TP53 CALD1
140 hemangioma 9.9 TP53 PGR ACTC1
141 skin sarcoma 9.9 FH CLEC2A CALD1
142 dermis tumor 9.9 FH CLEC2A CALD1
143 glomus tumor 9.8 TP53 CALD1 ACTC1
144 keratosis, seborrheic 9.8 TP53 CLEC2A
145 mucinous adenocarcinoma 9.8 TP53 PGR ESR1
146 bartholin's gland adenoma 9.8 TP53 PGR ESR1
147 bartholin's gland benign neoplasm 9.8 TP53 PGR ESR1
148 vestibular gland benign neoplasm 9.8 TP53 PGR ESR1
149 ovarian seromucinous carcinoma 9.8 TP53 PGR ESR1
150 comedo carcinoma 9.8 TP53 PGR ESR1
151 inflammatory myofibroblastic tumor 9.8 TP53 CALD1 ACTC1
152 endosalpingiosis 9.8 TP53 PGR ESR1
153 breast sarcoma 9.8 TP53 PGR ESR1
154 intraductal breast neoplasm 9.8 TP53 PGR ESR1
155 microglandular adenosis 9.8 TP53 PGR ESR1
156 hypertrophy of breast 9.8 TP53 PGR ESR1
157 female reproductive endometrioid cancer 9.8 TP53 PGR ESR1
158 endocervical carcinoma 9.8 TP53 PGR ESR1
159 lobular neoplasia 9.8 TP53 PGR ESR1
160 endocervical adenocarcinoma 9.8 TP53 PGR ESR1
161 tonsil cancer 9.8 TP53 PGR ESR1
162 uterine corpus cancer 9.8 TP53 PGR ESR1
163 luminal breast carcinoma 9.8 TP53 PGR ESR1
164 clear cell adenocarcinoma 9.8 TP53 PGR ESR1
165 adenomyosis 9.8 TP53 PGR ESR1
166 pelvic organ prolapse 9.8 TP53 PGR ESR1
167 fallopian tube carcinoma 9.8 TP53 PGR ESR1
168 female breast cancer 9.8 TP53 PGR ESR1
169 pre-malignant neoplasm 9.8 TP53 PGR ESR1
170 juvenile nasopharyngeal angiofibroma 9.8 PGR PCNA ESR1 ACTC1
171 sporadic breast cancer 9.8 TP53 PGR ESR1
172 estrogen-receptor positive breast cancer 9.8 TP53 PGR ESR1
173 in situ carcinoma 9.8 TP53 PGR ESR1
174 ovary adenocarcinoma 9.8 TP53 PGR ESR1
175 breast carcinoma in situ 9.8 TP53 PGR ESR1
176 endometrial hyperplasia 9.8 TP53 PGR ESR1
177 fasciitis 9.8 TP53 ESR1 ACTC1
178 sweat gland neoplasm 9.8 TP53 CLEC2A CALD1
179 ductal carcinoma in situ 9.8 TP53 PGR ESR1
180 malignant ovarian surface epithelial-stromal neoplasm 9.8 TP53 PGR ESR1
181 ovary epithelial cancer 9.8 TP53 PGR ESR1
182 breast cancer 9.8
183 larynx leiomyoma 9.8
184 kidney cancer 9.8
185 prostate leiomyoma 9.8
186 myofibroma 9.8
187 uterine inversion 9.8
188 syncope 9.8
189 teratoma 9.8 TP53 ESR1 ACTC1
190 breast ductal carcinoma 9.8 TP53 PGR ESR1
191 cardiovascular cancer 9.7 TP53 CALD1
192 ovarian clear cell adenocarcinoma 9.7 TP53 PGR
193 uterine anomalies 9.7 TP53 PGR ESR1
194 peritoneal benign neoplasm 9.7 PGR MED12 FH CALD1
195 adenomyoma 9.7 PGR MED12 ESR1 CALD1
196 vulvar leiomyoma 9.6 PGR ESR1 CLEC2A CALD1
197 vulvar benign neoplasm 9.6 PGR ESR1 CLEC2A CALD1
198 peritoneal mesothelioma 9.6 PGR ESR1
199 thoracic cancer 9.6 TP53 PGR ESR1
200 breast leiomyoma 9.6 PGR FH ESR1 CLEC2A
201 adenosarcoma 9.6 TP53 PGR ESR1 ACTC1
202 ovarian disease 9.6 TP53 PGR ESR1
203 uterine carcinosarcoma 9.6 TP53 PGR PCNA ESR1
204 breast malignant phyllodes tumor 9.5 TP53 PGR MED12 ESR1
205 meningioma, familial 9.5 TP53 PGR PCNA ESR1
206 thoracic benign neoplasm 9.5 TP53 PGR MED12 ESR1
207 breast benign neoplasm 9.5 TP53 PGR MED12 ESR1
208 breast fibroadenoma 9.5 TP53 PGR MED12 ESR1
209 papilloma 9.5 TP53 PCNA ESR1 ACTC1
210 breast adenocarcinoma 9.5 TP53 PGR MED12 ESR1
211 sweat gland cancer 9.5 TP53 PGR ESR1 CLEC2A
212 wilms tumor 1 9.5 TP53 PGR MED12 ESR1
213 cervical mucinous adenocarcinoma 9.5 TP53 PGR ESR1 CALD1
214 vaginal cancer 9.5 TP53 PGR ESR1 CALD1
215 mixed cell type cancer 9.5 TP53 PGR ESR1 CALD1
216 breast disease 9.4 TP53 PGR ESR1
217 muscular disease 9.2 TP53 PGR ESR1 CALD1 ACTC1
218 cell type benign neoplasm 9.1 TP53 PGR FH ESR1 CALD1
219 endometrial stromal sarcoma 9.0 TP53 PGR PCNA ESR1 CALD1 ACTC1
220 uterine benign neoplasm 8.8 TP53 PGR MED12 FH ESR1 CALD1
221 reproductive organ benign neoplasm 8.8 TP53 PGR MED12 FH ESR1 CALD1

Graphical network of the top 20 diseases related to Bizarre Leiomyoma:



Diseases related to Bizarre Leiomyoma

Symptoms & Phenotypes for Bizarre Leiomyoma

GenomeRNAi Phenotypes related to Bizarre Leiomyoma according to GeneCards Suite gene sharing:

26 (showing 1, show less)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435) GR00104-A-0 8.8 ESR1 FH PCNA

Drugs & Therapeutics for Bizarre Leiomyoma

Interventional clinical trials:

(showing 1, show less)
# Name Status NCT ID Phase Drugs
1 Concordance Between Gynaecologic Sonography Amd Pelvic MRI for the Pre-surgical Diagnosis of Uterine Mesenchimal Malignant Tumors Unknown status NCT02940041

Search NIH Clinical Center for Bizarre Leiomyoma

Genetic Tests for Bizarre Leiomyoma

Anatomical Context for Bizarre Leiomyoma

MalaCards organs/tissues related to Bizarre Leiomyoma:

40
Breast, Uterus, Smooth Muscle, Ovary, Prostate, Colon, Liver

Publications for Bizarre Leiomyoma

Articles related to Bizarre Leiomyoma:

(showing 81, show less)
# Title Authors PMID Year
1
The First Described Case of Bizarre Leiomyoma of the Portal Vein. 61
31779764 2019
2
MVP immunohistochemistry is a useful adjunct in distinguishing leiomyosarcoma from leiomyoma and leiomyoma with bizarre nuclei. 61
29307622 2018
3
Primary inferior vena cava smooth muscle tumor with diffuse bizarre giant nuclei and low mitotic rate: a nomenclatural conundrum. 61
28623706 2017
4
Leiomyomatosis peritonealis disseminata: A case report and review of the literature. 61
27284430 2016
5
Case report: Atypical, 'symplastic' leiomyoma recurring as leiomyosarcoma in the vagina. 61
26793761 2015
6
Bizarre leiomyoma of uterus/smooth muscle tumor of uncertain malignant potential: A diagnostic dilemma. 61
26960523 2015
7
Literature review of outcomes and prevalence and case report of leiomyosarcomas and non-typical uterine smooth muscle leiomyoma tumors treated with uterine artery embolization. 61
26117442 2015
8
An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas. 61
26045786 2015
9
[Analysis of the risk factors for postoperative residue, relapse following myomectomy]. 61
25354860 2014
10
Potential diagnostic biomarkers: differential expression of LMP2/β1i and cyclin B1 in human uterine leiomyosarcoma. 61
25296613 2014
11
Bizarre leiomyoma of the scrotum: A case report and review of the literature. 61
24765204 2014
12
Endometrioid carcinoma infiltrating atypical leiomyoma: a mimicker of malignant mixed Mullerian tumor. 61
24943777 2014
13
Pelvic periprostatic symplastic leiomyoma: an unusual case necessitating a radical surgery. 61
23771381 2013
14
Symplastic leiomyoma in the suprarenal inferior vena cava. 61
23599711 2012
15
FDG-PET/CT findings of atypical (bizarre/symplastic) uterine leiomyoma in a patient with abdominal leiomyosarcoma. 61
27326292 2012
16
Removal of a large bizarre uterine leiomyoma by operative hysteroscopy. Case report and review of the literature. 61
22675972 2012
17
Symplastic leiomyoma of uterus--a clinico-pathological dilemma. 61
22674600 2011
18
Uterine smooth muscle tumors of uncertain malignant potential and atypical leiomyoma: a morphological study of these grey zones with clinical correlation. 61
22234095 2011
19
Successful pregnancy outcome after laparoscopic-assisted excision of a bizarre leiomyoma: a case report. 61
21812974 2011
20
Atypical (symplastic) leiomyoma of the uterus--a case report. 61
22041803 2011
21
Smooth muscle neoplasms of the urinary bladder: a clinicopathologic study of 51 cases. 61
20154594 2010
22
Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy. 61
20179432 2010
23
Cutaneous leiomyomas and leiomyosarcomas: an immunohistochemical study with p53. 61
20495746 2010
24
Suprarenal symplastic leiomyoma of the inferior vena cava. 61
19733033 2009
25
Molecular and immunohistochemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas. 61
19633649 2009
26
Atypical leiomyoma: An unusual variant of cutaneous pilar leiomyoma. 61
19379650 2009
27
A rare symplastic or bizarre leiomyoma of the scrotum: a case report and review of the literature. 61
19068127 2008
28
Bizarre leiomyoma of the posterior vaginal fornix. 61
18501906 2008
29
Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors. 61
18580309 2008
30
Symplastic leiomyoma of uterus: a rare histological variant. 61
18541089 2008
31
A case of cutaneous symplastic leiomyoma - a rare variant of cutaneous pilar leiomyoma. 61
18251750 2008
32
Uterine leiomyomas with inclusion bodies: an immunohistochemical and ultrastructural analysis of 12 cases. 61
17306931 2007
33
Symplastic hemangioma: report of two cases. 61
17083693 2006
34
Myxoid symplastic leiomyoma of the uterus. 61
16753760 2006
35
Bizarre leiomyoma of the soft tissue. 61
16194835 2005
36
Bizarre leiomyoma of scrotum. 61
16146275 2005
37
Cutaneous leiomyoma with cytologic atypia, akin to uterine symplastic leiomyoma. 61
15355371 2004
38
Pathologic quiz case: a 40-year-old woman with a large pelvic mass, ascites, massive right hydrothorax, and elevated CA 125. Uterine symplastic leiomyoma associated with pseudo-Meigs syndrome and elevated CA 125. 61
15270600 2004
39
[Atypical or bizarre leiomyoma of the scrotum. Report of one case and bibliographic review]. 61
15270287 2004
40
Pathologic quiz case: a 69-year-old asymptomatic man with a scrotal mass. Atypical (symplastic or bizarre) leiomyoma of the scrotum. 61
14736263 2004
41
[The differential diagnosis between uterine leiomyosarcoma and the special subtypes of leiomyoma]. 61
14521746 2003
42
Bizarre leiomyoma of the scrotum. 61
12808340 2003
43
Atypical (bizarre) leiomyoma of the nasal cavity with prominent myxoid change. 61
12401830 2002
44
[A clinicopathological study of bizarre leiomyoma]. 61
12485480 2002
45
Mesenchymal tumors of muscularis mucosae of colon and rectum are benign leiomyomas that should be separated from gastrointestinal stromal tumors--a clinicopathologic and immunohistochemical study of eighty-eight cases. 61
11598163 2001
46
Atypical pilar leiomyoma: cutaneous counterpart of uterine symplastic leiomyoma? 61
11481520 2001
47
Bizarre leiomyoma of the vagina: report of a case. 61
10782419 2000
48
Bizarre leiomyoma of the epididymis. A case report. 61
11517827 2000
49
Association of multiple familial cutaneous leiomyoma with a uterine symplastic leiomyoma. 61
10671972 2000
50
Expression of cyclins and cyclin-dependent kinases in smooth muscle tumors of the uterus. 61
10371341 1999
51
Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas. 61
9891238 1999
52
Mast cells in smooth muscle tumors of the uterus. 61
9785134 1998
53
Reduced expression of calponin h1 in leiomyosarcoma of the uterus. 61
9690561 1998
54
Bizarre leiomyomas of the uterus: a comprehensive pathologic study of 24 cases with long-term follow-up. 61
9351564 1997
55
[Subcutaneous myolipoma with bizarre cells: morphological, immunohistochemical and ultrastructural study of a case and review of the literature]. 61
9411363 1997
56
Bizarre leiomyoma of the prostate. 61
9126110 1997
57
Symplastic leiomyoma of the scrotum. A case report. 61
8767397 1996
58
[Symplastic leiomyoma combined with focal adenocarcinoma of the endometrium]. 61
9045564 1996
59
Recurrence of a renal myogenic tumor presented as a duodenal ulcerated lesion. 61
8586368 1995
60
[Histological diagnosis and clinical features in borderline smooth muscle tumors of the uterus]. 61
8082439 1994
61
Neoplastic association of leiomyoma, bizarre leiomyoma and leiomyosarcoma uteri. Case report. 61
7828608 1994
62
[Myoid tumors of the stomach. Our experience]. 61
8290154 1993
63
Cytogenetic findings in a symplastic leiomyoma. 61
8504405 1993
64
Vulvar leiomyoma. 61
8385861 1993
65
Bladder leiomyoma in pregnancy: a case report. 61
1297239 1992
66
Extragenital metastases to uterine leiomyomata. A case report. 61
1324313 1992
67
[Bizarre leiomyoma of the uterus--a clinicopathological analysis of 21 cases]. 61
2076641 1990
68
Complex karyotypic anomalies in a bizarre leiomyoma of the uterus. 61
2487152 1989
69
Bizarre leiomyoma of the renal pelvis with ultrastructural and immunohistochemical findings. 61
2926892 1989
70
Bizarre leiomyoma of the prostate. 61
3125678 1988
71
[A case of bizarre leiomyoma of the scrotum]. 61
3314425 1987
72
[A case of bizarre leiomyoma of the duodenum]. 61
3842908 1985
73
Uterine bizarre leiomyoma. 61
7113686 1982
74
Histogenesis of morphologic variations in tumors of the uterine wall. 61
7361995 1980
75
Vascular leiomyosarcoma: the malignant counterpart of vascular leiomyoma. 61
498039 1979
76
Giant leiomyoma of the stomach. 61
933940 1976
77
[Stout's bizarre leiomyoma]. 61
4434786 1974
78
Bizarre leiomyoma of the stomach: Case report. 61
5266968 1970
79
A comprative electron microscopic study of a leiomyosarcoma and bizarre leiomyoma (leiomyoblastoma) of the stomach. 61
5820970 1969
80
[Rare case of multiple nodular gastric tumor (Stout's bizarre leiomyoma) associated with pulmonary amartochondroma in a 12-year-old girl]. 61
5403584 1969
81
Bizarre leiomyoma (leiomyoblastoma). Report of a case. 61
14009016 1962

Variations for Bizarre Leiomyoma

Expression for Bizarre Leiomyoma

Search GEO for disease gene expression data for Bizarre Leiomyoma.

Pathways for Bizarre Leiomyoma

Pathways related to Bizarre Leiomyoma according to GeneCards Suite gene sharing:

(showing 6, show less)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
11.86 TP53 PSMB9 PCNA ESR1
2 10.94 TP53 ESR1
3 10.87 TP53 ESR1
4 10.87 TP53 MED12 ESR1
5 10.76 TP53 PCNA
6 10.62 TP53 PCNA

GO Terms for Bizarre Leiomyoma

Cellular components related to Bizarre Leiomyoma according to GeneCards Suite gene sharing:

(showing 1, show less)
# Name GO ID Score Top Affiliating Genes
1 replication fork GO:0005657 8.62 TP53 PCNA

Biological processes related to Bizarre Leiomyoma according to GeneCards Suite gene sharing:

(showing 4, show less)
# Name GO ID Score Top Affiliating Genes
1 transcription initiation from RNA polymerase II promoter GO:0006367 9.33 PGR MED12 ESR1
2 embryonic organ development GO:0048568 9.26 TP53 MED12
3 positive regulation of RNA polymerase II transcriptional preinitiation complex assembly GO:0045899 8.96 TP53 ESR1
4 negative regulation of production of miRNAs involved in gene silencing by miRNA GO:1903799 8.62 TP53 ESR1

Molecular functions related to Bizarre Leiomyoma according to GeneCards Suite gene sharing:

(showing 5, show less)
# Name GO ID Score Top Affiliating Genes
1 histone acetyltransferase binding GO:0035035 9.32 TP53 PCNA
2 steroid binding GO:0005496 9.26 PGR ESR1
3 chromatin binding GO:0003682 9.26 TP53 PCNA MED12 ESR1
4 myosin binding GO:0017022 9.16 CALD1 ACTC1
5 enzyme binding GO:0019899 8.92 TP53 PGR PCNA ESR1

Sources for Bizarre Leiomyoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....